Dr. Reddy's Laboratories Ltd

Ladies and gentlemen, good day and welcome to the Q4 and FY21 earnings conference call of Dr. Reddy's Laboratories Ltd. As a reminder, all parent-spend lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star 10-0 on your touchstone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Amit Agarwal, Head of Investor Relations at Dr. Reddy's Laboratories Ltd. Thank you and over to you, Mr. Agarwal.

Thank you. Very good morning and good evening to all of you. And thank you for joining us today for the Dr. Reddy's Earnings Conference Call for the quarter and fully-arranged March 31, 2021. Earlier during the day, we have released our results and the same are also posted on our website. This call is being recorded and the playback and transcripts shall be made available on our website soon. All the discussions and analysis of this call will be based on the IFRS consolidated financial statements. To discuss the business performance and outlook, we have the leadership team of Dr. Reddy's, comprising Mr. J.V. Prasad, our co-chairman and managing director, Mr. Erez Israeli, our CEO, Mr. Parag Agarwal, our CFO, and the investor relations team. Please note that today's call is a copyrighted material of Dr. Reddy's and cannot be rebroadcasted or attributed in press or media outlet without the company's expressed written consent.

Before